Core Viewpoint - Huajian Medical (01931) plans to acquire approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of its total issued share capital, for about HKD 3.142 billion, making Huajian the largest single shareholder of Guofu Quantum after the transaction [1] Group 1: Acquisition Details - The acquisition price for Guofu Quantum shares is approximately HKD 3.142 billion [1] - After the acquisition, Huajian Medical will hold 20.31% of Guofu Quantum's total issued share capital [1] Group 2: Strategic Importance - This acquisition is a key move for Huajian Medical to advance its strategy of establishing a Real World Asset (RWA) tokenization exchange [1] - Huajian Medical possesses extensive resources in the medical industry, while Guofu Quantum has strong capabilities in financial technology [1] Group 3: Resource Sharing and Synergy - Huajian Medical can leverage Guofu Quantum's 22.5% stake in Southern Dongying to collaboratively build a blockchain and financial technology-centric on-chain financial ecosystem [1] - The new platform aims to integrate compliant digital architecture with traditional asset forms, promoting asset tokenization, fragmentation, and cross-border flow [1]